Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
trivalent influenza vaccine
- Development stage
- Approved
- Lead developer
- Sanofi Pasteur
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular, Intradermal, Intranasal
01
Overview
The 2011-2012 Seasonal Flu Vaccine was a trivalent inactivated influenza vaccine containing three viral strains: A/California/7/2009 (H1N1)-like virus, A/Perth/16/2009 (H3N2)-like virus, and B/Brisbane/60/2008-like virus (B Victoria lineage). It was designed to provide protection against influenza during the 2011-2012 influenza season. The vaccine stimulates the immune system to produce antibodies against the included influenza strains, providing protection against infection. Multiple formulations were available, including standard intramuscular injections, intradermal versions, high-dose versions for older adults, and live attenuated nasal spray versions.
- Brand names
- FluzoneFluzone High-DoseFluzone IntradermalFluMistAfluriaFluadIntanza
- Other names
- 2011-2012 Seasonal Flu VaccineSeasonal influenza vaccine
02
Targets
HA (Hemagglutinin)Neuraminidase
Beyond the preview
Go deeper on trivalent influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on trivalent influenza vaccine.